MATINAS BIOPHARMA HOLDINGS, INC.

Profile

Company Names

MATINAS BIOPHARMA HOLDINGS, INC.

Addresses

1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ 07921

915 KLOSTERMAN ROAD EAST, TARPON SPRINGS, FL 34689

600 W. GERMANTOWN PIKE, SUITE 400, PLYMOUTH MEETING, PA 19462

Phone Numbers

908-443-1860
610-771-0680

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$39,512,215.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2025-02-13 
$1,650,000.00 
$3,300,000.00 
$1,650,000.00 
Equity 
5
2017-01-13 
$15,483,175.00 
$15,483,175.00 
$0.00 
 
4
2016-07-29 
$4,400,290.00 
$8,000,000.00 
$3,599,710.00 
Equity 
3
2015-03-31 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
2
2013-07-30 
$7,593,750.00 
$15,000,000.00 
$7,406,250.00 
Equity 
1
2013-07-11 
$385,000.00 
$385,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GEORGE 
 
BOBOTAS 
EXECUTIVE OFFICER
HERBERT 
 
CONRAD 
DIRECTOR
ERIC 
 
ENDE 
DIRECTOR
ABDEL 
A. 
FAWZY 
EXECUTIVE OFFICER
STEFANO 
 
FERRARI 
DIRECTOR
GARY 
 
GAGLIONE 
EXECUTIVE OFFICER
STEPHEN 
HARRINGTON 
EXECUTIVE OFFICER, DIRECTOR
JEROME 
 
JABBOUR 
DIRECTOR, EXECUTIVE OFFICER
DOUGLAS 
F. 
KLING 
EXECUTIVE OFFICER
KEITH 
 
KUCINSKI 
EXECUTIVE OFFICER
RAPHAEL 
J. 
MANNINO 
EXECUTIVE OFFICER
ROELOF 
 
RONGEN 
EXECUTIVE OFFICER, DIRECTOR
JAMES 
 
SCIBETTA 
DIRECTOR
ROBIN 
 
SMITH 
DIRECTOR
ADAM 
 
STERN 
DIRECTOR
PROLOR BIOTECH, INC.   |  LABSTYLE INNOVATIONS CORP.   |  MATINAS BIOPHARMA HOLDINGS, INC.   |  TCG PRIVATE SELECT PARTNERS, L.P.   |  DANCE BIOPHARM INC.   |  360 ENERGY OPPORTUNITY FUND, LP   |  ELEVEN JAMES, INC.   |  DANCE BIOPHARM HOLDINGS, INC.   |  ATLAS ENHANCED ACCESS FUND LP   |  GC OPPORTUNITIES I PRIVATE FUND, LP   |  FUNDAMENTAL PARTNERS III ACCESS FUND LP   |  TCG PRIVATE SELECT PARTNERS II, L.P.   |  CCA PINECREST INVESTORS, LP   |  COBBLESTONE PRIVATE REAL ESTATE FUND, LP   |  REAL ESTATE SENIOR LOAN ACCESS FUND, LP   |  PEAK MULTIFAMILY I ACCESS FUND, LP   |  LGA INCOME PLUS FUND, LP   |  GC OPPORTUNITIES 2 PRIVATE FUND LP   |  HCA SPECIAL OPPORTUNITIES FUND, LP   |  HCA GLOBAL ALPHA FUND LP   |  HCA GLOBAL ALPHA FUND OFFSHORE LTD   |  COBBLESTONE PRIVATE CREDIT FUND, LP   |  EMPIRICAL ALTERNATIVE INCOME FUND, LP   |  ALIGN IMPACT FUND II, LP   |  HCA WINDACRE ACCESS FUND, LP   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES BIG DATA I   |  AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES PLANT PROTEIN I   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES PLANT PROTEIN I   |  HYDROFARM HOLDINGS GROUP, INC.   |  SHOREPOINT INCOME FUND I LP   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES HOSPITALITY I   |  TCG PRIVATE SELECT PARTNERS III LP   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES FANTASY SPORTS I   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH I   |  AERAMI THERAPEUTICS HOLDINGS, INC.   |  DARIOHEALTH CORP.   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES DIGITAL FREIGHT NETWORK I   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH III   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES AGRITECH II   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES FINTECH I   |  AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES AGRITECH II   |  SPRING TARGETED OPPORTUNITY III LLC   |  AGRITECH QP PARTNERS LLC - SERIES HB-1   |  AGRITECH PARTNERS LLC - SERIES HB-1   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH IV   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES BIG DATA II   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES AEROSPACE II   |  SPRING TARGETED OPPORTUNITY IV LLC   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH V   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES HEALTHTECH I   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH VI   |  AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES MEDTECH VI   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES FINTECH III   |  AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES MEDTECH IV   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH VIII   |  AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES MEDTECH VIII   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH VII   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES AEROSPACE III   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH IX   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH X   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH II   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH XII   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH XI   |  PURSUIT FUND ADVISERS LLC   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES AEROSPACE IV   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES BIG DATA III   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES DAS I
MATTHEW 
 
WIKLER 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-02-13 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2017-01-13 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-07-29 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-03-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
AEGIS CAPITAL CORP.
NONE
NONE
AEGIS CAPITAL CORP.
NONE
NONE
NYPPEX, LLC
NONE
NONE
KINGSBURY CAPITAL LLC